April 12, 2022 – Nutrition counseling and strictly limiting salt intake for one year in patients with heart failure resulted in improved quality of life and a slowing in the progression of the disease, but a study presented at the American College of Cardiology’s (ACC) 71st Annual Scientific Session found reducing salt intake did not significantly reduce major adverse events or hospitalizations.
April 12, 2022 – Biotricity, a medical diagnostic and consumer healthcare technology company, will officially launch the commercial sales of its FDA cleared, wireless wearable cardiac monitoring device, Biotres, in April 2022.
April 12, 2022 – Siemens Healthineers, the global leader in intracardiac echocardiography (ICE), announced the market introduction of the next-generation AcuNav Volume ICE catheter in the United States. With over 10 years of experience in 4D Volume ICE,  this new product continues the company’s innovation journey in structural heart and electrophysiology imaging.
April 12, 2022 – While golfing was once known as the game of kings, the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health for all, says you don’t have to be royalty or a professional player to reap health benefits from hitting the links at your local golf course.
April 12, 2022 – BIOTRONIK has announced introduction of a new mobile app update for cardiac device patients which is designed to facilitate exchange with clinical staff and to better engage patients in their care.
April 12, 2022 – A majority of patients with obstructive hypertrophic cardiomyopathy (HCM)—a condition that results in excess thickening of the heart muscle—who were candidates for a procedure to relieve the obstruction of blood flow out of the heart no longer needed the surgery after taking the investigational drug mavacamten for 16 weeks, in a phase 3 study presented at the American College of Cardiology’s 71st Annual Scientific Session.